Log In
Print
BCIQ
Print
Print this Print this
 

GSK249320

Also known as: 249320

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionAntibody against myelin associated glycoprotein (MAG)
Molecular Target Myelin associated glycoprotein (MAG)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationStroke
Indication DetailsTreat stroke
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today